TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
P3 Health Partners ( (PIII) ) has issued an update.
On November 11, 2025, P3 Health Partners REACH ACO, LLC entered into an agreement with Commonwealth Primary Care ACO, LLC to form P3 Commonwealth Innovation MSO, LLC. This new entity will manage and coordinate activities for ACOs, focusing on shared services, financial management, and clinical integration. The MSO will receive management fees and a portion of net shared savings from the ACOs, with P3 ACO holding an 80% membership interest. The formation of this MSO is expected to enhance the operational efficiency and quality of care provided by the involved ACOs.
The most recent analyst rating on (PIII) stock is a Sell with a $6.50 price target. To see the full list of analyst forecasts on P3 Health Partners stock, see the PIII Stock Forecast page.
Spark’s Take on PIII Stock
According to Spark, TipRanks’ AI Analyst, PIII is a Underperform.
P3 Health Partners faces significant financial challenges, with high leverage and negative profitability metrics being the most impactful factors. Technical indicators suggest bearish momentum, and valuation metrics are unattractive due to ongoing losses. While the earnings call provided some positive strategic insights, near-term financial hurdles remain substantial.
To see Spark’s full report on PIII stock, click here.
More about P3 Health Partners
P3 Health Partners is a company operating in the healthcare industry, focusing on accountable care organizations (ACOs) and providing management and administrative services to improve performance and quality of healthcare programs.
Average Trading Volume: 6,481
Technical Sentiment Signal: Strong Sell
Current Market Cap: $54.77M
See more data about PIII stock on TipRanks’ Stock Analysis page.